NCT06058546

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

A Randomized, Double-blind, Placebo-controlled, Multi-center Phase II Clinical Trial of Efficacy and Safety of Jiuweihuaban Pill in the Treatment of Moderate to Severe Plaque Psoriasis(Syndrome of Blood-heat ).

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 180 (estimated)
• Sponsor: Tasly Pharmaceutical Group Co., Ltd · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the efficacy and safety of Jiuweihuaban Pill in the treatment of moderate to severe plaque psoriasis(syndrome of blood-heat ).

Conditions

• Plaque Psoriasis

Interventions

Type	Name	Description
DRUG	Jiuweihuaban Pill placebo	Jiuweihuaban pill placebo 1 bag(12 g placebo per bag),p.o.,tid,for 12weeks.
DRUG	low dose Jiuweihuaban Pill	Low dose Jiuweihuaban pill 1 bag(3 g placebo per bag and 9 g Jiuweihuaban pill ),p.o.,tid,for 12weeks.
DRUG	high dose Jiuweihuaban Pill	High dose Jiuweihuaban pill 1 bag(12 g Jiuweihuaban pill ),p.o.,tid,for 12weeks.

Timeline

• Start date: 2023-11-23
• Primary completion: 2025-10-01
• Completion: 2025-10-01
• First posted: 2023-09-28
• Last updated: 2024-09-03

Locations

12 sites across 1 country: China